Macrophage Function and the Role of GSK3

被引:24
|
作者
Patel, Sarvatit [1 ,2 ]
Werstuck, Geoff H. [1 ,2 ,3 ]
机构
[1] Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L9L 2X2, Canada
[2] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
[3] McMaster Univ, Dept Med, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
关键词
macrophage function; glycogen synthase kinase (GSK)-3; molecular mechanisms; inflammatory response; atherosclerosis; GLYCOGEN-SYNTHASE KINASE-3-BETA; PI3K/AKT/GSK-3-BETA SIGNALING PATHWAY; SKELETAL-MUSCLE; ATTENUATES ATHEROSCLEROSIS; INDUCED APOPTOSIS; DOWN-REGULATION; KINASE; ACTIVATION; INHIBITION; CELLS;
D O I
10.3390/ijms22042206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages are present in nearly all vertebrate tissues, where they respond to a complex variety of regulatory signals to coordinate immune functions involved in tissue development, metabolism, homeostasis, and repair. Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed protein kinase that plays important roles in multiple pathways involved in cell metabolism. Dysregulation of GSK3 has been implicated in several prevalent metabolic disorders, and recent findings have highlighted the importance of GSK3 activity in the regulation of macrophages, especially with respect to the initiation of specific pathologies. This makes GSK3 a potential therapeutic target for the development of novel drugs to modulate immunometabolic responses. Here, we summarize recent findings that have contributed to our understanding of how GSK3 regulates macrophage function, and we discuss the role of GSK3 in the development of metabolic disorders and diseases.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
    Gozdz, Agata
    Nikolaienko, Oleksii
    Urbanska, Malgorzata
    Cymerman, Iwona A.
    Sitkiewicz, Ewa
    Blazejczyk, Magdalena
    Dadlez, Michal
    Bramham, Clive R.
    Jaworski, Jacek
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
  • [22] GSK3β is a negative regulator of platelet function and thrombosis
    Li, Dongjun
    August, Shelley
    Woulfe, Donna S.
    BLOOD, 2008, 111 (07) : 3522 - 3530
  • [23] The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment
    Dimou, Anastasios
    Syrigos, Konstantinos N.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] GSK3β: role in therapeutic landscape and development of modulators
    Phukan, S.
    Babu, V. S.
    Kannoji, A.
    Hariharan, R.
    Balaji, V. N.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (01) : 1 - 19
  • [25] The renaissance of GSK3
    Philip Cohen
    Sheelagh Frame
    Nature Reviews Molecular Cell Biology, 2001, 2 : 769 - 776
  • [26] The renaissance of GSK3
    Cohen, P
    Frame, S
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) : 769 - 776
  • [27] A GSK3 lockdown
    Alison Schuldt
    Nature Reviews Molecular Cell Biology, 2011, 12 (2) : 72 - 72
  • [28] The role of GSK3 in metabolic pathway perturbations in cancer
    Papadopoli, David
    Pollak, Michael
    Topisirovic, Ivan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (08):
  • [29] Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
    Chelko, Stephen P.
    Asimaki, Angeliki
    Andersen, Peter
    Bedja, Djahida
    Amat-Alarcon, Nuria
    DeMazumder, Deeptankar
    Jasti, Ravirasmi
    MacRae, Calum A.
    Leber, Remo
    Kleber, Andre G.
    Saffitz, Jeffrey E.
    Judge, Daniel P.
    JCI INSIGHT, 2016, 1 (05)
  • [30] Antagonistic role of GSK3 isoforms in glioma survival
    Vashishtha, Vidhi
    Jinghan, Nupur
    Yadav, Ajay K.
    JOURNAL OF CANCER, 2018, 9 (10): : 1846 - 1855